Results 251 to 260 of about 99,964 (316)
Real-World Functional and Anatomical Outcomes of Intravitreal Faricimab in Suboptimal Responders With Neovascular Age-Related Macular Degeneration: A 24-Month Clinical Audit. [PDF]
CureusSukumaran D +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab
Ophthalmology, 2020PURPOSE To evaluate the features and outcomes of eyes with retinal vasculitis and intraocular inflammation (IOI) after intravitreal injection (IVI) of brolucizumab 6mg/0.05ml for treatment of neovascular age-related macular degeneration (AMD).
Tommaso Bacci +2 more
exaly +2 more sources
Complications of intravitreal injections: 2022
Current Opinion in Ophthalmology, 2022Purpose of review This review highlights the complications of both intravitreal injection procedure as well as different intravitreal medications including antivascular endothelial growth factors, antibiotics, antivirals, antifungals, methotrexate, and ...
Dillan Patel +3 more
semanticscholar +1 more source
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
Pharmaceutics, 2019 Intravitreal administration of anti-vascular endothelial growth factor (VEGF) antibodies has become the standard treatment for Age-Related Macular Degeneration; however, the knowledge of their pharmacokinetics is limited.
Cristina Mondelo-García +2 more
exaly +2 more sources
Pharmaceutics, 2020 Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due to the complex anatomy and physiology of the eye. Intravitreal injection is the mainstream route of drug administration to the posterior segment of the ...
Giacinto Triolo +2 more
exaly +2 more sources
Ophthalmology, 2014 PURPOSE To evaluate the safety and efficacy of dexamethasone intravitreal implant (Ozurdex, DEX implant) 0.7 and 0.35 mg in the treatment of patients with diabetic macular edema (DME).
Young Hee Yoon +2 more
exaly +2 more sources
Progress in retinal and eye research, 2020
Intravitreal injections have become the most commonly performed intraocular treatments worldwide. Because intravitreal injections may induce severe adverse events, such as infectious and noninfectious endophthalmitis, cataract, ocular hypertension ...
G. Melo +10 more
semanticscholar +1 more source
Intravitreal injections have become the most commonly performed intraocular treatments worldwide. Because intravitreal injections may induce severe adverse events, such as infectious and noninfectious endophthalmitis, cataract, ocular hypertension ...
G. Melo +10 more
semanticscholar +1 more source
The Clearance of Intravitreal Gentamicin
American Journal of Ophthalmology, 1981Intravitreal gentamicin cleared significantly more rapidly from the uninflamed aphakic rabbit eye than the phakic control, with a half-life of 12 hours in the former and 32 hours in the latter. A similar difference was noted in aphakic and phakic eyes with an experimental Staphylococcus aureus endophthalmitis, but without the same level of ...
L M, Cobo, R K, Forster
openaire +2 more sources
Intravitreal Injection of Piperacillin
Ophthalmic Surgery, Lasers and Imaging Retina, 1989ABSTRACT Piperacillin was injected into the vitreous body of rabbit eyes to evaluate its suitability for intraocular injection and its toxicity on intraocular tissues. Doses ranged from 50 µg to 3,000 µg. Toxicity was determined through histology and electroretinograms by comparing the piperacillin-injected eyes with eyes injected with ...
H C, Semple, J C, Liu, G A, Peyman
openaire +2 more sources